Teleflex Announces First Patient Enrollment in CTO-PCI IDE Study

NEXT STORY
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
PREV STORY
Toronto centre solving cell manufacturing challenges to benefit patients and global industry
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pascal Biosciences Expands Leadership Team to Support Strategic Advancement of Its Cannabinoid Based Programs

VANCOUVER, B.C. and SEATTLE, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) ...

author_avatar
NASDAQ Market News

Novartis data at ASCO, ICML and EHA meetings demonstrate meaningful advancements in cancer care

Updated analyses from the Kisqali® pivotal Phase III MONALEESA-2 trial in hormone receptor positive, ...

author_avatar
NASDAQ Market News

PolarityTE Provides Update on Key Opinion Leader Event and Addresses Misleading Report

SALT LAKE CITY, June 27, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) today announced ...

author_avatar
NASDAQ Market News